These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 10099885)

  • 1. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM.
    Vleming LJ; van der Pijl JW; Lemkes HH; Westendorp RG; Maassen JA; Daha MR; van Es LA; van Kooten C
    Clin Nephrol; 1999 Mar; 51(3):133-40. PubMed ID: 10099885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the DD genotype and development of Japanese type 2 diabetic nephropathy.
    Gohda T; Makita Y; Shike T; Kobayashi M; Funabiki K; Haneda M; Kikkawa R; Watanabe T; Baba T; Yoshida H; Tomino Y
    Clin Nephrol; 2001 Dec; 56(6):475-80. PubMed ID: 11770799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S; Blohmé G; Sylvén C; Mulec H
    Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting-enzyme gene and diabetic nephropathy in IDDM patients.
    Pfohl M; Frost D; Koch M; Clemens P; Patzies A; Schmülling RM; Beischer W; Häring HU
    Horm Metab Res; 1998 May; 30(5):276-80. PubMed ID: 9660089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
    Yu ZY; Chen LS; Zhang LC; Zhou TB
    Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.
    Barnas U; Schmidt A; Illievich A; Kiener HP; Rabensteiner D; Kaider A; Prager R; Abrahamian H; Irsigler K; Mayer G
    Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE gene polymorphism, left ventricular geometry, and mortality in diabetic patients with end-stage renal disease.
    Sakka Y; Babazono T; Sato A; Ujihara N; Iwamoto Y
    Diabetes Res Clin Pract; 2004 Apr; 64(1):41-9. PubMed ID: 15036826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis.
    Pereira TV; Nunes AC; Rudnicki M; Magistroni R; Albertazzi A; Pereira AC; Krieger JE
    Nephrol Dial Transplant; 2006 Nov; 21(11):3155-63. PubMed ID: 16935894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.
    Marre M; Jeunemaitre X; Gallois Y; Rodier M; Chatellier G; Sert C; Dusselier L; Kahal Z; Chaillous L; Halimi S; Muller A; Sackmann H; Bauduceau B; Bled F; Passa P; Alhenc-Gelas F
    J Clin Invest; 1997 Apr; 99(7):1585-95. PubMed ID: 9120002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of allele D of angiotensin-converting enzyme polymorphism is associated with diabetic nephropathy in patients with less than 10 years duration of Type 2 diabetes.
    Canani LH; Costa LA; Crispim D; Gonçalves Dos Santos K; Roisenberg I; Lisbôa HR; Sarturi Tres G; Maia AL; Gross JL
    Diabet Med; 2005 Sep; 22(9):1167-72. PubMed ID: 16108844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Angiotensin converting enzyme (ACE) gene polymorphism in a diabetic cohort and diabetic nephropathy].
    Levinson O; Oren S; Yagil C; Sapojnikov M; Wechsler A; Bloch R; Yagil Y
    Harefuah; 1999 May; 136(10):768-73, 843. PubMed ID: 10955109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.
    Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY
    Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
    Fanelli A; Hadjadj S; Gallois Y; Fumeron F; Betoule D; Grandchamp B; Marre M
    Arch Mal Coeur Vaiss; 2002; 95(7-8):701-8. PubMed ID: 12365083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians.
    Movva S; Alluri RV; Komandur S; Vattam K; Eppa K; Mukkavali KK; Mubigonda S; Saharia S; Shastry JC; Hasan Q
    J Diabetes Complications; 2007; 21(4):237-41. PubMed ID: 17616353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
    Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
    Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients.
    Arfa I; Abid A; Nouira S; Elloumi-Zghal H; Malouche D; Mannai I; Zorgati MM; Ben Alaya N; Rebai A; Zouari B; Ben Ammar S; Ben Rayana MC; Hmida S; Blousa-Chabchoub S; Abdelhak S
    J Renin Angiotensin Aldosterone Syst; 2008 Mar; 9(1):32-6. PubMed ID: 18404607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients.
    Park HC; Choi SR; Kim BS; Lee TH; Kang BS; Choi KH; Lee HY; Han DS; Ha SK
    Yonsei Med J; 2005 Dec; 46(6):779-87. PubMed ID: 16385653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients.
    Akman B; Tarhan C; Arat Z; Sezer S; Ozdemir FN
    Ren Fail; 2009; 31(3):196-200. PubMed ID: 19288324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism.
    Vegter S; Perna A; Hiddema W; Ruggenenti P; Remuzzi G; Navis G; Postma MJ
    Pharmacogenet Genomics; 2009 Sep; 19(9):695-703. PubMed ID: 19696696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.